CAMBRIDGE, Mass., March 12 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation
at the Eleventh Annual Lehman Brothers Global Healthcare Conference will be
webcast live and may be accessed by visiting the Investors section of the
Company's website, http://www.millennium.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
The presentation will include an update on VELCADE(R) (bortezomib) for
Injection and product candidates in the development pipeline. The
presentation will be delivered at 8:30 a.m. ET on Wednesday, March 19, 2008
from the Loews Miami Beach Hotel in Miami, FL. The presentation will be
archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a
novel cancer product, and has a robust clinical development pipeline of
product candidates. The Company's research, development and
commercialization activities are focused in two therapeutic areas: oncology
and inflammation. By applying its knowledge of the human genome,
understanding of disease mechanisms and industrialized drug discovery
platform, Millennium is developing an exciting pipeline of innovative
product candidates. The Company's website is http://www.millennium.com.
Editors' Note: This press release is also available under the Media
section of the Company's website at: http://www.millennium.com.
Contact:
Kyle Kuvalanka
(617) 761-4734
SOURCE Millennium Pharmaceuticals, Inc.
 back to top
Related links:
http://www.millennium.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http://photoarchive.ap.org PRN Photo Desk
photodesk@prnewswire.com
http://www.prnewswire.com/comp/114562.html/
CONTACT:
Kyle Kuvalanka of Millennium Pharmaceuticals,
Inc., +1-617-761-4734
|
